Clinical Trials Directory

Trials / Completed

CompletedNCT02527902

Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy

Autonomic Nervous System (ANS) Analysis According to Different Renal Function Stage in Immunoglobin A (IgA) Nephropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The estimation of the cardiovascular risk in the general population must take into account small renal disturbances, as the microalbuminuria. Conversely certain parameters of the cardiovascular risk influence the evolution of renal diseases, for example the arterial high blood pressure. The measure of the activity of the autonomous nervous system, and especially the quantification of its variability, is a means to estimate the cardiovascular risk. The investigators formulate the hypothesis that the variability of the autonomous nervous system is an additional clinical element for the evaluation of the evolutionary risk of renal diseases. The aim of this study is to compare the variability of the autonomous nervous system during the various evolutionary stages of the renal disease. The renal disease studied will be IgA nephropathy (IgNA). IgNA is a histologically defined glomerulonephritis (rela biopsy) by the presence of deposits immunoglobulin A (IgA) in the renal mesangium (at list 1+) by immunofluorescence.

Conditions

Interventions

TypeNameDescription
DEVICEHoltermeasure of ANS in IgAN patients

Timeline

Start date
2011-01-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2015-08-19
Last updated
2015-08-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02527902. Inclusion in this directory is not an endorsement.